Allstate Corporation’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Sell
20,965
-39,109
-65% -$904K 0.01% 1018
2026
Q1
$1.44M Buy
+60,074
New +$1.47M 0.02% 658
2022
Q4
Sell
-34,332
Closed -$426K 588
2022
Q3
$426K Buy
+34,332
New +$600K 0.01% 528
2022
Q1
Sell
-63,550
Closed -$1.8M 639
2021
Q4
$1.8M Buy
+63,550
New +$1.98M 0.03% 421
2021
Q3
Sell
-7,558
Closed -$262K 702
2021
Q2
$262K Sell
7,558
-1,377
-15% -$45.4K 0.01% 675
2021
Q1
$263K Buy
8,935
+1,135
+15% +$34.9K 0.01% 675
2020
Q4
$239K Buy
+7,800
New +$238K 0.01% 671
2020
Q2
Sell
-10,277
Closed -$230K 684
2020
Q1
$230K Buy
+10,277
New +$281K 0.01% 560
2019
Q3
Sell
-36,488
Closed -$1.23M 500
2019
Q2
$1.23M Buy
+36,488
New +$1.18M 0.02% 367

Other funds holding ELAN

Allstate Corporation's ELAN Position: Q2 2026 in Review

Allstate Corporation reduced its Elanco Animal Health (ELAN) stake by 65% in Q2 2026, selling an estimated $904K and leaving 20,965 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #1018.

Allstate Corporation first reported a position in ELAN in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.8M in Q4 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Allstate Corporation held 20,965 shares of Elanco Animal Health worth $516K as of Q2 2026.
  • Allstate Corporation sold 39,109 Elanco Animal Health shares in Q2 2026, an estimated $904K.
  • Elanco Animal Health made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #1018 holding.
  • Allstate Corporation first reported a position in Elanco Animal Health in Q2 2019 and has held it in 9 quarters since.
  • Allstate Corporation's Elanco Animal Health position peaked at $1.8M in Q4 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.